Clinical Trial Detail

NCT ID NCT02065466
Title Combo of Abraxane, TMZ, Bevacizumab in Metastatic Melanoma With Brain Metastases
Recruitment Withdrawn
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors University of Arizona
Indications

melanoma

Therapies

Bevacizumab + Nab-paclitaxel + Temozolomide

Age Groups: adult senior

No variant requirements are available.